 Timothy Whitehead
Concepts (338)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein Engineering | 19 | 2026 | 122 | 8.060 |
Why?
| | Biosensing Techniques | 8 | 2026 | 142 | 4.060 |
Why?
| | High-Throughput Nucleotide Sequencing | 8 | 2024 | 530 | 2.420 |
Why?
| | Spike Glycoprotein, Coronavirus | 4 | 2025 | 129 | 2.250 |
Why?
| | Mutation | 16 | 2025 | 4075 | 2.170 |
Why?
| | Arabidopsis Proteins | 5 | 2026 | 76 | 2.160 |
Why?
| | Biotechnology | 6 | 2023 | 45 | 1.890 |
Why?
| | Escherichia coli | 13 | 2024 | 835 | 1.820 |
Why?
| | Epitope Mapping | 5 | 2018 | 61 | 1.770 |
Why?
| | Synthetic Biology | 3 | 2024 | 16 | 1.750 |
Why?
| | DNA-Directed RNA Polymerases | 2 | 2026 | 62 | 1.750 |
Why?
| | Proteins | 10 | 2022 | 1023 | 1.730 |
Why?
| | Gene Library | 8 | 2023 | 122 | 1.580 |
Why?
| | Epitopes | 6 | 2024 | 473 | 1.570 |
Why?
| | DNA Mutational Analysis | 3 | 2024 | 407 | 1.560 |
Why?
| | Viral Proteins | 2 | 2026 | 350 | 1.480 |
Why?
| | Antibodies, Neutralizing | 5 | 2025 | 340 | 1.460 |
Why?
| | Antibodies, Monoclonal | 5 | 2024 | 1505 | 1.400 |
Why?
| | Protein Binding | 17 | 2024 | 2238 | 1.360 |
Why?
| | DNA | 3 | 2023 | 1435 | 1.290 |
Why?
| | Mutagenesis, Site-Directed | 3 | 2022 | 376 | 1.180 |
Why?
| | Protein Stability | 4 | 2024 | 176 | 1.150 |
Why?
| | Mutagenesis | 8 | 2023 | 194 | 1.130 |
Why?
| | Arabidopsis | 3 | 2025 | 93 | 1.080 |
Why?
| | Genetic Fitness | 2 | 2019 | 56 | 1.080 |
Why?
| | Plant Growth Regulators | 3 | 2024 | 6 | 1.070 |
Why?
| | Saccharomyces cerevisiae | 4 | 2021 | 573 | 1.070 |
Why?
| | Antibodies | 3 | 2019 | 397 | 0.960 |
Why?
| | Propionates | 1 | 2026 | 39 | 0.950 |
Why?
| | Plasmids | 5 | 2023 | 373 | 0.920 |
Why?
| | Ligands | 7 | 2025 | 665 | 0.920 |
Why?
| | Cell Adhesion Molecules | 2 | 2018 | 181 | 0.910 |
Why?
| | Models, Molecular | 18 | 2026 | 1598 | 0.900 |
Why?
| | Lignin | 2 | 2016 | 58 | 0.870 |
Why?
| | Molecular Dynamics Simulation | 2 | 2024 | 265 | 0.860 |
Why?
| | Amidohydrolases | 3 | 2019 | 31 | 0.840 |
Why?
| | Sequence Analysis, DNA | 3 | 2016 | 777 | 0.830 |
Why?
| | Protein Interaction Domains and Motifs | 6 | 2021 | 145 | 0.820 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2024 | 56 | 0.820 |
Why?
| | Molecular Chaperones | 5 | 2009 | 199 | 0.800 |
Why?
| | Plant Proteins | 1 | 2024 | 111 | 0.790 |
Why?
| | Protein Folding | 4 | 2024 | 276 | 0.770 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2026 | 345 | 0.760 |
Why?
| | DNA, Single-Stranded | 2 | 2023 | 117 | 0.760 |
Why?
| | Water Pollutants, Chemical | 1 | 2026 | 227 | 0.750 |
Why?
| | Phosphotransferases | 3 | 2017 | 26 | 0.740 |
Why?
| | Immunoglobulin Heavy Chains | 2 | 2021 | 86 | 0.720 |
Why?
| | Receptors, Cell Surface | 1 | 2024 | 372 | 0.700 |
Why?
| | Directed Molecular Evolution | 1 | 2022 | 28 | 0.700 |
Why?
| | Immunoglobulin Variable Region | 1 | 2021 | 80 | 0.690 |
Why?
| | beta-Lactamases | 3 | 2017 | 53 | 0.680 |
Why?
| | Green Fluorescent Proteins | 4 | 2019 | 407 | 0.680 |
Why?
| | Antibodies, Viral | 2 | 2025 | 674 | 0.670 |
Why?
| | Binding Sites | 9 | 2022 | 1310 | 0.660 |
Why?
| | Indoles | 1 | 2024 | 507 | 0.650 |
Why?
| | Oncostatin M Receptor beta Subunit | 1 | 2020 | 1 | 0.640 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2021 | 174 | 0.640 |
Why?
| | Receptors, Interleukin | 1 | 2020 | 43 | 0.630 |
Why?
| | Bioengineering | 1 | 2020 | 20 | 0.630 |
Why?
| | Antibody Affinity | 3 | 2025 | 60 | 0.630 |
Why?
| | Biochemistry | 1 | 2020 | 36 | 0.620 |
Why?
| | Personality | 1 | 2021 | 129 | 0.600 |
Why?
| | Atropa belladonna | 1 | 2019 | 1 | 0.590 |
Why?
| | Oligodeoxyribonucleotides | 1 | 2019 | 141 | 0.580 |
Why?
| | Metabolic Engineering | 3 | 2025 | 36 | 0.580 |
Why?
| | Acyltransferases | 1 | 2019 | 78 | 0.560 |
Why?
| | Mutant Proteins | 2 | 2018 | 105 | 0.560 |
Why?
| | Interleukins | 1 | 2020 | 248 | 0.560 |
Why?
| | Cell Surface Display Techniques | 1 | 2018 | 13 | 0.550 |
Why?
| | Nerve Growth Factor | 1 | 2018 | 36 | 0.540 |
Why?
| | Yeasts | 1 | 2018 | 51 | 0.540 |
Why?
| | Carrier Proteins | 1 | 2022 | 728 | 0.540 |
Why?
| | Enzyme Stability | 4 | 2026 | 73 | 0.510 |
Why?
| | Gene Products, tat | 1 | 2017 | 22 | 0.510 |
Why?
| | Analgesics, Opioid | 1 | 2026 | 1149 | 0.500 |
Why?
| | Computational Biology | 6 | 2015 | 669 | 0.500 |
Why?
| | Cellulase | 1 | 2016 | 32 | 0.490 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2016 | 130 | 0.460 |
Why?
| | Promoter Regions, Genetic | 2 | 2024 | 1246 | 0.460 |
Why?
| | Point Mutation | 1 | 2016 | 240 | 0.460 |
Why?
| | Hemagglutinin Glycoproteins, Influenza Virus | 2 | 2012 | 29 | 0.440 |
Why?
| | Coumaric Acids | 1 | 2014 | 4 | 0.440 |
Why?
| | Selection, Genetic | 1 | 2017 | 261 | 0.440 |
Why?
| | Kluyveromyces | 2 | 2025 | 10 | 0.440 |
Why?
| | Liquid-Liquid Extraction | 1 | 2014 | 13 | 0.440 |
Why?
| | High-Throughput Screening Assays | 1 | 2017 | 176 | 0.430 |
Why?
| | Fermentation | 1 | 2014 | 31 | 0.430 |
Why?
| | Recombinant Proteins | 5 | 2016 | 1368 | 0.430 |
Why?
| | Software | 4 | 2016 | 680 | 0.430 |
Why?
| | Haplotypes | 1 | 2016 | 499 | 0.410 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2018 | 414 | 0.400 |
Why?
| | Peptide Library | 4 | 2018 | 91 | 0.400 |
Why?
| | Antigens, Neoplasm | 1 | 2015 | 271 | 0.400 |
Why?
| | Genome | 1 | 2016 | 305 | 0.390 |
Why?
| | Evolution, Molecular | 1 | 2017 | 492 | 0.390 |
Why?
| | Glucose | 2 | 2015 | 1048 | 0.390 |
Why?
| | Peptides | 2 | 2017 | 998 | 0.380 |
Why?
| | Anterior Cruciate Ligament Injuries | 3 | 2021 | 218 | 0.380 |
Why?
| | Cell Cycle Proteins | 1 | 2016 | 630 | 0.370 |
Why?
| | Models, Biological | 1 | 2019 | 1764 | 0.360 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2014 | 337 | 0.360 |
Why?
| | Nanotechnology | 3 | 2009 | 114 | 0.340 |
Why?
| | Anterior Cruciate Ligament Reconstruction | 3 | 2019 | 193 | 0.340 |
Why?
| | Models, Genetic | 3 | 2021 | 524 | 0.340 |
Why?
| | Drug Discovery | 1 | 2012 | 153 | 0.330 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2012 | 159 | 0.320 |
Why?
| | Fungal Proteins | 2 | 2025 | 143 | 0.320 |
Why?
| | Abscisic Acid | 3 | 2025 | 6 | 0.320 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2015 | 1217 | 0.320 |
Why?
| | Bacterial Proteins | 2 | 2016 | 967 | 0.320 |
Why?
| | Methanococcus | 2 | 2007 | 10 | 0.310 |
Why?
| | Membrane Proteins | 1 | 2016 | 1164 | 0.310 |
Why?
| | Amino Acid Substitution | 2 | 2024 | 302 | 0.310 |
Why?
| | Cloning, Molecular | 2 | 2023 | 538 | 0.300 |
Why?
| | Dimerization | 3 | 2023 | 189 | 0.290 |
Why?
| | Circular Dichroism | 2 | 2026 | 151 | 0.290 |
Why?
| | Solubility | 3 | 2019 | 240 | 0.280 |
Why?
| | Algorithms | 2 | 2016 | 1845 | 0.280 |
Why?
| | Protein Conformation | 6 | 2018 | 938 | 0.280 |
Why?
| | Gene Deletion | 1 | 2009 | 391 | 0.260 |
Why?
| | Biomass | 3 | 2016 | 96 | 0.260 |
Why?
| | Two-Hybrid System Techniques | 2 | 2017 | 59 | 0.250 |
Why?
| | Ketoprofen | 1 | 2026 | 2 | 0.240 |
Why?
| | Antiviral Agents | 1 | 2012 | 769 | 0.240 |
Why?
| | Monoterpenes | 1 | 2025 | 11 | 0.230 |
Why?
| | Bacteriophage T7 | 1 | 2024 | 5 | 0.220 |
Why?
| | Small Molecule Libraries | 1 | 2025 | 111 | 0.210 |
Why?
| | Genetic Vectors | 2 | 2023 | 335 | 0.210 |
Why?
| | Benzoxazines | 1 | 2024 | 31 | 0.210 |
Why?
| | Germinal Center | 1 | 2025 | 64 | 0.210 |
Why?
| | Complementarity Determining Regions | 1 | 2024 | 54 | 0.210 |
Why?
| | Naphthalenes | 1 | 2024 | 54 | 0.210 |
Why?
| | Biofouling | 1 | 2023 | 8 | 0.200 |
Why?
| | CRISPR-Cas Systems | 1 | 2025 | 166 | 0.200 |
Why?
| | Morpholines | 1 | 2024 | 130 | 0.200 |
Why?
| | Temperature | 2 | 2026 | 633 | 0.200 |
Why?
| | Amino Acid Sequence | 6 | 2018 | 2129 | 0.200 |
Why?
| | Gene Expression | 3 | 2017 | 1476 | 0.190 |
Why?
| | Humans | 18 | 2025 | 145474 | 0.190 |
Why?
| | Protein Domains | 2 | 2022 | 311 | 0.180 |
Why?
| | Thermodynamics | 2 | 2016 | 419 | 0.180 |
Why?
| | Antigens | 1 | 2024 | 348 | 0.180 |
Why?
| | Tibial Meniscus Injuries | 2 | 2019 | 62 | 0.170 |
Why?
| | Archaeal Proteins | 3 | 2009 | 50 | 0.170 |
Why?
| | Hormones | 1 | 2022 | 135 | 0.170 |
Why?
| | Drug Stability | 1 | 2021 | 169 | 0.170 |
Why?
| | Cannabinoids | 1 | 2023 | 184 | 0.170 |
Why?
| | Drug Approval | 1 | 2021 | 93 | 0.170 |
Why?
| | DNA Breaks, Single-Stranded | 2 | 2020 | 5 | 0.160 |
Why?
| | Plants | 1 | 2022 | 167 | 0.160 |
Why?
| | Protein Interaction Mapping | 2 | 2011 | 105 | 0.160 |
Why?
| | United States Food and Drug Administration | 1 | 2021 | 208 | 0.160 |
Why?
| | Protein Structure, Secondary | 3 | 2016 | 371 | 0.160 |
Why?
| | Databases, Genetic | 1 | 2021 | 238 | 0.160 |
Why?
| | Microscopy, Electron, Transmission | 3 | 2009 | 156 | 0.160 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2024 | 673 | 0.160 |
Why?
| | Bacteriophage phi X 174 | 1 | 2020 | 5 | 0.160 |
Why?
| | Knee Joint | 3 | 2021 | 428 | 0.150 |
Why?
| | Cats | 1 | 2020 | 231 | 0.150 |
Why?
| | Penicillin Amidase | 2 | 2009 | 2 | 0.150 |
Why?
| | Genetic Engineering | 1 | 2020 | 88 | 0.150 |
Why?
| | Belladonna Alkaloids | 1 | 2019 | 1 | 0.150 |
Why?
| | Luminescent Agents | 1 | 2019 | 7 | 0.150 |
Why?
| | Transition Temperature | 1 | 2019 | 28 | 0.150 |
Why?
| | Membrane Glycoproteins | 1 | 2022 | 499 | 0.150 |
Why?
| | Transcription, Genetic | 2 | 2024 | 1454 | 0.140 |
Why?
| | Biosynthetic Pathways | 1 | 2019 | 24 | 0.140 |
Why?
| | Codon, Nonsense | 1 | 2019 | 44 | 0.140 |
Why?
| | Biocatalysis | 2 | 2015 | 67 | 0.140 |
Why?
| | Pertussis Toxin | 1 | 2018 | 24 | 0.140 |
Why?
| | Pertussis Vaccine | 1 | 2018 | 24 | 0.140 |
Why?
| | Models, Chemical | 2 | 2010 | 250 | 0.140 |
Why?
| | Osteonecrosis | 1 | 2018 | 23 | 0.140 |
Why?
| | Genome, Viral | 1 | 2020 | 214 | 0.130 |
Why?
| | Flow Cytometry | 3 | 2018 | 1162 | 0.130 |
Why?
| | Antibodies, Bacterial | 1 | 2018 | 147 | 0.130 |
Why?
| | Bordetella pertussis | 1 | 2017 | 4 | 0.130 |
Why?
| | Adenylate Cyclase Toxin | 1 | 2017 | 6 | 0.130 |
Why?
| | Aspergillus niger | 1 | 2017 | 10 | 0.130 |
Why?
| | Protein Conformation, beta-Strand | 1 | 2017 | 18 | 0.130 |
Why?
| | Protein Conformation, alpha-Helical | 1 | 2017 | 18 | 0.130 |
Why?
| | Acetamides | 1 | 2017 | 41 | 0.130 |
Why?
| | Gait | 2 | 2018 | 312 | 0.130 |
Why?
| | Arthroscopy | 1 | 2019 | 268 | 0.130 |
Why?
| | Mutation, Missense | 1 | 2019 | 335 | 0.130 |
Why?
| | DNA Restriction Enzymes | 1 | 2016 | 53 | 0.120 |
Why?
| | Hydrolysis | 1 | 2017 | 197 | 0.120 |
Why?
| | Cell Separation | 1 | 2018 | 305 | 0.120 |
Why?
| | Amides | 1 | 2017 | 101 | 0.120 |
Why?
| | Substrate Specificity | 1 | 2017 | 387 | 0.120 |
Why?
| | Genes, Bacterial | 1 | 2016 | 152 | 0.120 |
Why?
| | DNA, Plant | 1 | 2016 | 17 | 0.120 |
Why?
| | Lipomyces | 1 | 2015 | 1 | 0.120 |
Why?
| | Area Under Curve | 1 | 2016 | 331 | 0.120 |
Why?
| | Glucose-6-Phosphate | 1 | 2015 | 6 | 0.120 |
Why?
| | Animals | 6 | 2021 | 38030 | 0.120 |
Why?
| | Osteoarthritis, Knee | 1 | 2019 | 280 | 0.120 |
Why?
| | Structure-Activity Relationship | 1 | 2017 | 563 | 0.110 |
Why?
| | Surface Properties | 1 | 2016 | 386 | 0.110 |
Why?
| | HIV | 1 | 2017 | 251 | 0.110 |
Why?
| | DNA, Neoplasm | 1 | 2016 | 158 | 0.110 |
Why?
| | Cellulose | 1 | 2015 | 58 | 0.110 |
Why?
| | Protein Transport | 1 | 2017 | 442 | 0.110 |
Why?
| | Bacterial Outer Membrane Proteins | 1 | 2015 | 62 | 0.110 |
Why?
| | ROC Curve | 1 | 2016 | 617 | 0.110 |
Why?
| | DNA, Bacterial | 1 | 2016 | 320 | 0.110 |
Why?
| | Running | 1 | 2016 | 233 | 0.100 |
Why?
| | Pseudomonas aeruginosa | 1 | 2016 | 395 | 0.100 |
Why?
| | Gene Expression Profiling | 2 | 2014 | 1767 | 0.100 |
Why?
| | Ribosomes | 1 | 2014 | 193 | 0.100 |
Why?
| | Kinetics | 3 | 2015 | 1567 | 0.100 |
Why?
| | Estrogen Receptor alpha | 1 | 2014 | 151 | 0.090 |
Why?
| | Thermosomes | 2 | 2009 | 2 | 0.090 |
Why?
| | Escherichia coli Proteins | 1 | 2014 | 201 | 0.090 |
Why?
| | Madin Darby Canine Kidney Cells | 1 | 2012 | 17 | 0.090 |
Why?
| | Neutralization Tests | 1 | 2012 | 76 | 0.090 |
Why?
| | Polymers | 2 | 2023 | 485 | 0.090 |
Why?
| | Sensitivity and Specificity | 1 | 2017 | 1997 | 0.090 |
Why?
| | Genotype | 1 | 2017 | 1852 | 0.090 |
Why?
| | Static Electricity | 1 | 2012 | 114 | 0.090 |
Why?
| | Walking | 1 | 2016 | 542 | 0.090 |
Why?
| | Gene Regulatory Networks | 1 | 2014 | 317 | 0.090 |
Why?
| | Computer-Aided Design | 1 | 2011 | 40 | 0.090 |
Why?
| | Crystallography, X-Ray | 2 | 2015 | 486 | 0.080 |
Why?
| | Dogs | 1 | 2012 | 458 | 0.080 |
Why?
| | Base Sequence | 2 | 2020 | 2170 | 0.080 |
Why?
| | Lipids | 1 | 2015 | 707 | 0.080 |
Why?
| | Nanowires | 1 | 2009 | 8 | 0.080 |
Why?
| | Myocytes, Cardiac | 1 | 2014 | 546 | 0.070 |
Why?
| | Protein Renaturation | 1 | 2009 | 4 | 0.070 |
Why?
| | Chaperonins | 1 | 2009 | 6 | 0.070 |
Why?
| | Cell Survival | 1 | 2012 | 1100 | 0.070 |
Why?
| | Methanobacterium | 1 | 2008 | 2 | 0.070 |
Why?
| | Calibration | 1 | 2008 | 152 | 0.070 |
Why?
| | Luminescent Proteins | 1 | 2009 | 186 | 0.070 |
Why?
| | Microscopy, Electron | 1 | 2008 | 414 | 0.070 |
Why?
| | Nanostructures | 1 | 2008 | 105 | 0.060 |
Why?
| | Bone Marrow | 2 | 2019 | 306 | 0.060 |
Why?
| | Chromatography, Gel | 1 | 2007 | 130 | 0.060 |
Why?
| | RNA-Binding Proteins | 1 | 2010 | 447 | 0.060 |
Why?
| | Computer Simulation | 1 | 2011 | 1003 | 0.060 |
Why?
| | Postoperative Complications | 1 | 2019 | 2970 | 0.060 |
Why?
| | Reproducibility of Results | 1 | 2014 | 3413 | 0.060 |
Why?
| | Retrospective Studies | 1 | 2025 | 17291 | 0.060 |
Why?
| | Muscle, Skeletal | 1 | 2016 | 1789 | 0.060 |
Why?
| | Trinitrotoluene | 1 | 2025 | 1 | 0.060 |
Why?
| | DNA Primers | 1 | 2007 | 505 | 0.060 |
Why?
| | Gene Expression Regulation, Archaeal | 1 | 2005 | 9 | 0.060 |
Why?
| | Growth Inhibitors | 1 | 2005 | 39 | 0.060 |
Why?
| | Chemokines, CC | 1 | 2005 | 33 | 0.050 |
Why?
| | Genome, Fungal | 1 | 2025 | 44 | 0.050 |
Why?
| | RNA | 1 | 2010 | 910 | 0.050 |
Why?
| | T-Cell Antigen Receptor Specificity | 1 | 2024 | 45 | 0.050 |
Why?
| | Muscle, Smooth | 1 | 2005 | 153 | 0.050 |
Why?
| | Biomechanical Phenomena | 2 | 2018 | 857 | 0.050 |
Why?
| | Magnetic Phenomena | 1 | 2023 | 10 | 0.050 |
Why?
| | United States | 1 | 2021 | 16098 | 0.050 |
Why?
| | Archaea | 1 | 2004 | 61 | 0.050 |
Why?
| | Disease Models, Animal | 1 | 2014 | 4560 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 3 | 2021 | 3904 | 0.050 |
Why?
| | Biomarkers | 1 | 2014 | 4295 | 0.050 |
Why?
| | Protein Multimerization | 2 | 2015 | 204 | 0.050 |
Why?
| | Membrane Transport Proteins | 1 | 2023 | 154 | 0.050 |
Why?
| | Molecular Sequence Data | 3 | 2015 | 2883 | 0.050 |
Why?
| | Patella | 1 | 2021 | 28 | 0.040 |
Why?
| | Vero Cells | 1 | 2021 | 83 | 0.040 |
Why?
| | Immunoglobulin Light Chains | 1 | 2021 | 52 | 0.040 |
Why?
| | Cryoelectron Microscopy | 1 | 2021 | 221 | 0.040 |
Why?
| | Antibody Formation | 1 | 2021 | 288 | 0.040 |
Why?
| | Cartilage | 1 | 2021 | 197 | 0.040 |
Why?
| | Capsid Proteins | 1 | 2020 | 94 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2021 | 741 | 0.040 |
Why?
| | Vaccines, Acellular | 1 | 2018 | 3 | 0.030 |
Why?
| | Victoria | 1 | 2018 | 22 | 0.030 |
Why?
| | Tibia | 1 | 2019 | 176 | 0.030 |
Why?
| | Protein Subunits | 1 | 2018 | 229 | 0.030 |
Why?
| | Knee Injuries | 1 | 2018 | 122 | 0.030 |
Why?
| | Time and Motion Studies | 1 | 2016 | 28 | 0.030 |
Why?
| | Phosphorylation | 2 | 2015 | 1707 | 0.030 |
Why?
| | Conserved Sequence | 1 | 2017 | 244 | 0.030 |
Why?
| | B-Lymphocytes | 1 | 2021 | 870 | 0.030 |
Why?
| | Transplantation, Autologous | 1 | 2016 | 300 | 0.030 |
Why?
| | Manganese | 1 | 2015 | 55 | 0.030 |
Why?
| | Cartilage, Articular | 1 | 2019 | 349 | 0.030 |
Why?
| | Magnesium | 1 | 2015 | 156 | 0.030 |
Why?
| | Fluorescence | 1 | 2015 | 159 | 0.030 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2015 | 331 | 0.030 |
Why?
| | Proline | 1 | 2015 | 82 | 0.030 |
Why?
| | Sequence Alignment | 1 | 2015 | 362 | 0.030 |
Why?
| | Adult | 4 | 2019 | 40777 | 0.030 |
Why?
| | Gene Ontology | 1 | 2014 | 53 | 0.030 |
Why?
| | Electromyography | 1 | 2016 | 419 | 0.030 |
Why?
| | Heat-Shock Proteins | 2 | 2005 | 139 | 0.030 |
Why?
| | Male | 5 | 2021 | 72842 | 0.030 |
Why?
| | Logistic Models | 1 | 2018 | 2134 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2014 | 749 | 0.020 |
Why?
| | Young Adult | 2 | 2019 | 14218 | 0.020 |
Why?
| | Lung | 1 | 2005 | 4106 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2019 | 2953 | 0.020 |
Why?
| | Prevalence | 1 | 2018 | 2865 | 0.020 |
Why?
| | Hydrogen Bonding | 1 | 2011 | 169 | 0.020 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2011 | 192 | 0.020 |
Why?
| | Monte Carlo Method | 1 | 2010 | 147 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2011 | 531 | 0.020 |
Why?
| | Methanol | 1 | 2009 | 44 | 0.020 |
Why?
| | Prospective Studies | 1 | 2021 | 8057 | 0.020 |
Why?
| | Female | 4 | 2019 | 78844 | 0.020 |
Why?
| | Amoxicillin | 1 | 2009 | 35 | 0.020 |
Why?
| | Time Factors | 1 | 2019 | 7123 | 0.020 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2009 | 179 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2014 | 3124 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2009 | 855 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 5904 | 0.020 |
Why?
| | Water | 1 | 2009 | 445 | 0.010 |
Why?
| | Oncostatin M | 1 | 2005 | 6 | 0.010 |
Why?
| | Receptors, Interleukin-4 | 1 | 2005 | 16 | 0.010 |
Why?
| | Chemokine CCL11 | 1 | 2005 | 25 | 0.010 |
Why?
| | Genome, Archaeal | 1 | 2004 | 12 | 0.010 |
Why?
| | Interleukin-4 | 1 | 2005 | 207 | 0.010 |
Why?
| | Interleukin-13 | 1 | 2005 | 146 | 0.010 |
Why?
| | Drug Synergism | 1 | 2005 | 354 | 0.010 |
Why?
| | Cold Temperature | 1 | 2005 | 206 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2005 | 288 | 0.010 |
Why?
| | Heat-Shock Response | 1 | 2004 | 77 | 0.010 |
Why?
| | STAT3 Transcription Factor | 1 | 2005 | 206 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2014 | 5983 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 977 | 0.010 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 848 | 0.010 |
Why?
| | Trans-Activators | 1 | 2005 | 396 | 0.010 |
Why?
| | Blotting, Western | 1 | 2005 | 1179 | 0.010 |
Why?
| | Hot Temperature | 1 | 2005 | 396 | 0.010 |
Why?
| | Aged | 1 | 2021 | 26153 | 0.010 |
Why?
| | Adaptation, Physiological | 1 | 2005 | 560 | 0.010 |
Why?
| | Signal Transduction | 1 | 2014 | 5216 | 0.010 |
Why?
| | Phylogeny | 1 | 2004 | 917 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2005 | 1480 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2005 | 2803 | 0.010 |
Why?
| | Mice | 1 | 2014 | 18329 | 0.010 |
Why?
|
|
Whitehead's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|